Skip to main navigation Skip to search Skip to main content

A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma. . .

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date12/19/14 → 12/18/26

Funding

  • Dana Farber Partners CancerCare Incorporated: $42,500.00